
معرفی
Prof. Wouter Boon holds the position of Professor of Innovation and Transition Studies at Utrecht University's Copernicus Institute of Sustainable Development. He previously served as Associate Professor (2020–2023) and Assistant Professor (2013–2020) at Utrecht, and as Assistant Professor at VU University Amsterdam (2008–2010). His research focuses on governance and dynamics of emerging technologies, particularly their role in societal transitions like sustainable healthcare and mobility. He emphasizes demand-side innovation systems, responsible scaling, user involvement in innovation processes, and policy frameworks for technologies such as pharmaceuticals, medical devices, and AI applications. Boon also coordinates the bachelor program in Science & Innovation Management and teaches courses on life sciences innovation and sustainable drug development. He leads stakeholder engagement in Utrecht University’s Open Science program and serves on the board of the Sustainability Transitions Research Network (STRN).
- Education: PhD in Innovation Studies (2004–2008) from Utrecht University, with research on user-producer interaction in pharmacogenomics innovations.
- Research Themes:
- Institutions for Open Societies (IOS)
- Pathways to Sustainability (PtS)
His research interests span theoretical areas such as transition studies, user-producer interactions, and market formation, with applied focus on pharmaceutical innovation, orphan drugs, regenerative medicine, and smart mobility. Notably, he investigates patient participation in rare disease drug development, socio-technical embedding of health technologies like genetic testing and novel imaging techniques, and regulatory mechanisms for medical products. Boon’s work also explores public-private partnerships addressing global challenges and the socio-political dimensions of innovation in transportation and urban development.
Recent articles highlight themes of responsible AI in healthcare, digital platforms for public value co-creation, and market formation strategies for sustainability transitions. His studies often bridge innovation policy with interdisciplinary collaboration, emphasizing the role of stakeholders in shaping equitable technological futures.
- Scientific Awards: None explicitly mentioned.
As an academic leader, Boon advises on innovation pathways for diabetes therapies and coordinates research programs involving multi-stakeholder engagement. His contributions include policy analyses for the EU’s pharmaceutical legislation and collaborative research on carsharing business models. He is actively involved in interdisciplinary initiatives like the Utrecht University Open Science program and STRN, fostering global networks for sustainability research.
Prof. Boon’s research infrastructure includes collaborations with institutions like the Rathenau Institute and academic hospitals, focusing on co-creating data infrastructures for rare cancers and exploring the ethical dimensions of medical technology adoption. His work underscores the importance of institutional entrepreneurship in enabling transformative changes across healthcare, mobility, and digital innovation sectors.

